Evidence map›Paper›PMID 32903741›Full record

ArticleFrontiers in neurology2020

Impact of Repetitive Transcranial Magnetic Stimulation on Neurocognition and Oxidative Stress in Relapsing-Remitting Multiple Sclerosis: A Case Report.

Eduardo Agüera, Javier Caballero-Villarraso, Montserrat Feijóo, Begoña M Escribano, María C Bahamonde, Cristina Conde, Alberto Galván, Isaac Túnez

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Eduardo AgüeraInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Javier Caballero-VillarrasoInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Montserrat FeijóoInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Begoña M EscribanoInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
María C BahamondeInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Cristina CondeInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Alberto GalvánInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Isaac TúnezInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Instituto Maimónides de Investigación Biomédica de Córdoba · ESHospital Universitario Reina Sofía · ESUniversity of Córdoba · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) is a neurodegenerative condition whose manifestation and clinical evolution can present themselves in very different ways. Analogously, its treatment has to be personalized and the patient's response may be idiosyncratic. At this moment there is no cure for it, in addition to its clinical course sometimes being torpid, with a poor response to any treatment. However, Transcranial Magnetic Stimulation (TMS) has demonstrated its usefulness as a non-invasive therapeutic tool for the treatment of some psychiatric and neurodegenerative diseases. Some studies show that the application of rTMS implies improvement in patients with MS at various levels, but the effects at the psychometric level and the redox profile in blood have never been studied before, despite the fact that both aspects have been related to the severity of MS and its evolution. Here we present the case of a woman diagnosed with relapsing-remitting multiple sclerosis (RRMS) at the age of 33, with a rapid progression of her illness and a poor response to different treatments previously prescribed for 9 years. In view of the patient's clinical course, a compassionate treatment with rTMS for 1 year was proposed. Starting from the fourth month of treatment, when reviewing the status of her disease, the patient denoted a clear improvement at different levels. There followed out psychometric evaluations and blood analyses, that showed both an improvement in her neuropsychological functions and a reduction in oxidative stress in plasma, in correspondence with therTMS treatment.

Indexed as

case reportcompassionate use trialdisabilitymultiple sclerosisneuroplasticityoxidative stresspsychometrytranscranial magnetic stimulation

Identifiers

PMID32903741
PMCPMC7438891
OpenAlexW3047757013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.